PubRank

H Soudeyns

Author PubWeight™ 20.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature 1994 5.68
2 Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy. Canadian Zidovudine Multi-Centre Study Group. AIDS 1989 3.19
3 The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci U S A 1997 2.24
4 Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. Proc Natl Acad Sci U S A 1997 1.99
5 Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy. Nat Med 1998 1.50
6 Biological comparison of wild-type and zidovudine-resistant isolates of human immunodeficiency virus type 1 from the same subjects: susceptibility and resistance to other drugs. Antimicrob Agents Chemother 1991 1.09
7 Analysis of the T-cell receptor beta-chain variable-region (V beta) repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbations of specific V beta segments in CD4+ T cells of the virus-positive twins. Proc Natl Acad Sci U S A 1994 1.07
8 Accumulation of human immunodeficiency virus-specific cytotoxic T lymphocytes away from the predominant site of virus replication during primary infection. Eur J Immunol 1997 1.00
9 Characterization of reverse transcriptase activity and susceptibility to other nucleosides of AZT-resistant variants of HIV-1. Results from the Canadian AZT Multicentre Study. Ann N Y Acad Sci 1990 0.86
10 Immunopathogenesis of HIV infection. AIDS Res Hum Retroviruses 1998 0.85
11 Effects of RU486 on HIV-1 replication. Nat Med 1997 0.80
12 T-cell receptor V beta-specific expansions in children from HIV-infected mothers. AIDS 1996 0.75
13 Study of the T cell receptor repertoire in viral immunodeficiency disease. Springer Semin Immunopathol 1996 0.75